ADA seeks feedback on recommendations for using light-based adjuncts in oral cancer detection

Public comment ends Feb. 6

The ADA Living Guideline Program is accepting comments through Feb. 6 on the third installment in a series of evidence-based recommendations for the early detection and management of oral cancer.

The latest set of recommendations addresses the use of light-based devices to determine the need for biopsy. The program previously sought feedback on recommendations related to brush cytology and vital staining adjuncts.

The ADA invites dentists, other health care professionals, patients, organizations and policymakers to share their expertise and insights to help shape the upcoming guidelines.

Comments can be submitted through ADA.org/guidelinecomments by Feb. 6. To take part, download and review the draft recommendations, register for an optional virtual listening session from 4-5 p.m. CST Feb. 3, and submit comments and feedback via the online form prior to the deadline. Attendance at the listening session is not required to provide feedback.

These new recommendations are part of the ADA’s ongoing collaboration with the University of Pennsylvania School of Dental Medicine to update a 2017 guideline on the evaluation of potentially malignant disorders, including oral cancer.

Established in 2025, the ADA Living Guideline Program seeks to provide oral health care providers and patients with more frequent evidence-based recommendations to advance oral and overall health. The program upholds the methodological rigor of traditional guidelines, but living guidelines are updated as soon as new evidence emerges and is carefully reviewed.

The ADA will review and incorporate feedback from the public comment period into the final recommendations on light-based adjuncts, which are expected to be published in mid-2026.